AI And HCTD De-Risking Trials For Accelerated Approval And Pipeline Optimization

This e-book explores how AI-powered Historical Clinical Trial Data (HCTD) is reshaping modern trial design for oncology and rare disease research. Drawing from regulatory-grade patient-level data across thousands of global studies, it shows how sponsors are using Synthetic Control Arms^®, advanced analytics, and external validation strategies to de-risk trials and accelerate approvals.

Through real-world applications in hematologic malignancies, solid tumors, and rare diseases, the book demonstrates how smarter trial design can overcome recruitment challenges, strengthen single-arm studies, reduce reliance on traditional control arms, and generate faster, more confident regulatory decisions. The result is a practical roadmap for building more patient-centric clinical trials that shorten timelines, improve decision-making, and maximize pipeline potential.